Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: series of questions which can change patient care.
- Who it may be relevant to
- Registry conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease (Stages 4 and 5). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
We propose the following hypotheses: * The use of herbal medicine is common among patients with chronic kidney disease in Réunion island. * This use could influence the progression of kidney disease in these patients. To assess the primary inclusion criterion, patients will be easily identified by nephrologists through existing follow-up. The questionnaires will be administered after this early identification by the investigators at each center. The primary evaluation criterion is straightforward: it aims to establish an overview of the use of herbal medicine in our patient population. This information is currently unavailable and remains crucial for measuring the extent of the issue. Our secondary criteria will involve more in-depth analysis of this use and an attempt to correlate the use of certain herbs with the rate of progression of kidney disease at one year. We targeted patients with moderate to end-stage chronic kidney disease (KDIGO classification 3 to 5), which are the stages typically included in kidney disease studies. Furthermore, these patients are the most likely to experience a greater annual progression of their kidney disease, and the effect of herbs on this progression could be investigated. Transplant patients were not included because they are more aware of the risks of not using herbal medicine due to their use of immunosuppressants.
Interventions
- Other series of questions which can change patient care
Series of question are about self medication with plants
Primary outcome measures
- Proportion of patients with stage 3 to 5 CKD using traditional herbal medicine at baseline [Time frame: baseline]
Eligibility criteria
Inclusion criteria
Individual:
- Adult
- Resident of Réunion Island and planning to remain on the island for the year following enrollment
- Chronic Kidney Disease Stage 3, 4, or 5, not on dialysis
- Under the care of a nephrologist
- Able to complete a questionnaire
- Registered with social security
Exclusion criteria
Individual:
- Kidney transplant recipient
- Adult under guardianship or legal protection
- Pregnant or breastfeeding women, or women planning a pregnancy during the enrollment period
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
France · 1 center
- Investigator Coordinator — Saint-Denis
Identifiers
NCT: NCT07444515 · 2025/RUN/0033